Healthcare investment & growth advisory
Health Acquisition Partners advises healthcare private equity investors and operators on the growth behind the deal: testing it before close, building it after acquisition and sustaining it through exit.
In a healthcare deal, patient growth is often the assumption that carries the valuation. It deserves the rigor applied to earnings.
Volume forecasts, de novo ramps and add-on lift all depend on how a platform wins new patients: what each one costs, where demand comes from, and whether the engine behind it holds through a change of ownership. We examine that engine with an investor’s discipline and an operator’s understanding of how it is built.
Private equity firmsOperating partnersPE-backed healthcare platforms
Expertise
Three engagements, each tied to a moment in the deal: before close, after acquisition, and through the hold period to exit.
01Before close
An evidence-based review of the patient-acquisition engine behind a target’s growth case: what new patients really cost, how efficiently marketing turns demand into visits, and whether the assumptions in the model hold.
02After acquisition
Turning the assumptions in the investment case into working growth systems: an acquired practice’s demand, intake and measurement brought onto the platform without losing patient volume in the transition.
03Hold period to exit
Sustained growth performance across platforms and portfolio companies: patient growth measured consistently, funded where it returns, and reported in terms a board and a future buyer will recognize.
How we work
We work alongside deal teams, operating partners and platform leadership, and we write for both sides of the table: the investment committee that has to decide, and the team that has to deliver.
Conclusions come from source data and are shown with it. Where the evidence is incomplete, we say so.
Findings are written for the investment committee and made actionable for the operating team.
We connect patient acquisition costs, conversion performance, and growth capacity to the financial assumptions driving healthcare investments.
The PMD Framework
Patient Marketing Diligence is HAP’s framework for testing whether a healthcare company’s patient acquisition is durable, measurable and scalable. It runs alongside financial, commercial and technical diligence.
HAP Insights
PMD Framework · Part 3
Tracing reported conversions to scheduled and attended appointments.
PMD Framework · Part 4
This is Dimension 4 of 7 in the Patient Marketing Diligence Framework, a standard for evaluating whether a…
PMD Framework · Part 5
This is Dimension 5 of 7 in the Patient Marketing Diligence Framework, a standard for evaluating whether a…
Start a conversation
Whether you are evaluating a target, integrating an acquisition or planning an exit, a first conversation is a working session on the deal, not a presentation.
